The Prediabetes Show, Episode 4: Metformin in Prediabetes - A Vaccination Pill for Diabetes Prevention in 65 Countries
In this Prediabates episode 4, joining us in today's discussion is Dr Mala Dharmalingam, Director and Head of Endocrinology at the Bangalore Endocrinology and Diabetes Center, Bengaluru, India and Dr Pramila Kalra, professor and Head of Department of Endocrinology, M S Ramaiah Medical College and Memorial hospital, Bengaluru, India. This episode will focus on Metformin in Prediabetes: A Vaccination Pill for Diabetes Prevention in 65 Countries.
India sits on a sugary iceberg—prediabetes now affects more people than type 2 diabetes. While lifestyle change remains the cornerstone of prevention, there is growing global recognition of the role of pharmacological support. Metformin is already approved for prediabetes in over 65 countries, including by the DCGI in India in 2022. With a long-standing track record of efficacy, safety, affordability, and ease of use, metformin is emerging as a practical option in diabetes prevention.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.